Experts estimate that CAR T-cell therapy can cost between $500,000 and $1,000,000. “CAR [T-cell therapy] is the most expensive Medicare diagnosis-related drug,” says Brian Koffman, MD, founder of the Chronic Lymphocytic Leukemia Society.